XNCR Q2 2019 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M

Gross Profit

-$14M-70.9% margin

Operating Income

-$20M-100.4% margin

Net Income

-$16M-82.3% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-82.6%

Cash Flow

Operating Cash Flow

$109M

Free Cash Flow

$107M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$685M

Total Liabilities

$77M

Stockholders' Equity

$608M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$0	—
Gross Profit	-$14M	-$23M	+40.8%
Operating Income	-$20M	-$28M	+30.8%
Net Income	-$16M	-$26M	+38.0%

Revenue Segments

License

$112M85%

Collaboration

$14M11%

Milestone

$4M3%

Royalty

$1M1%